openPR Logo
Press release

What's driving the Cell Line Development Market growth? GE Healthcare, Thermo Fisher Scientific, Lonza Group, Cytovance Biologics, Sartorius, Corning, Selexis, Vista Biologicals, EuBiologics, Paragon Bioservices, Cobra Biologics, Patheon, Samsung Biologic

03-23-2020 06:57 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from:

/ PR Agency:
Cell Line Development Market,

Cell Line Development Market,

Market Study Report LLC adds new research on Cell Line Development market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Cell Line Development market also includes an in-depth study of the industry's competitive scenario.

U.S. cell line development market valued around USD 1.1 billion in 2017 and estimated to grow considerably during the forecast timeframe. Launch of sophisticated cell line development technologies, well-established healthcare infrastructure and large-scale production of protein therapeutics will drive the U.S. cell line development market during the forecast timeframe.

Request a sample of this premium report at:

Increasing incidences of cancer coupled with growing demand for monoclonal antibodies and vaccines will drive cell line development market. Rising prevalence of cancer has become major healthcare concern globally, hence government and several other organizations are conducting extensive research to reduce disease burden one of such approach includes cancer cell line development. Cell Line Development Market will reach over USD 7.5 billion by 2024; as per a new research report.

High alcohol and tobacco consumption coupled with unhealthy food and physical inactivity will escalate number of cancer incidences. Growth of biotechnology sector will positively impact cell line development market growth. Biotechnology based applications of cell line industry includes cell culture, drug discovery and gene therapy will grow significantly in coming future.

Patent expiration of blockbuster biologics such as Neupogen leading to development of new biosimilars should increase demand for human and animal cell lines. Thereby, accelerating industry expansion. Technological advancements in cell line development including automated screening methods, disposable equipment, enriched medias, improved expression systems and monitoring processes will drive industry growth. However, stringent regulations along with various concerns associated with stem cell research will hamper industry growth over the coming years.

Few notable industry players operating in cell line development market are GE Healthcare, Thermo Fisher Scientific, Lonza Group, Sigma-Aldrich Corporation (Merck), Cytovance Biologics, WuXi AppTec, Sartorius, Corning, Selexis, Vista Biologicals, EuBiologics, Paragon Bioservices, Cobra Biologics, Patheon, Samsung Biologics, NAEJA RGM Pharmaceuticals, GVK BIO, Catalent and others. Industry players are focusing towards expanding business portfolio to consolidate their market position as well as increase consumer base. For instance, In February 2017, Lonza entered into strategic partnership with Sanofi, that aimed at building mammalian cell facilities to produce monoclonal antibodies in Switzerland.

Reagents and media product segment dominated the industry in 2017 owing to high usage of reagents and media in tissue engineering, toxicity testing, research, bioproduction, development of regenerative medicine and others. It forms essential component for cell line development and cell culture procedures will drive industry growth. Non-mammalian source segment is estimated to grow considerably during the forecast period owing to high application in insecticide screening and toxicology study.

Based on application type, the industry is bifurcated into bioproduction, toxicity testing, drug discovery, tissue engineering and research. Tissue engineering segment will witness robust growth rate during the forecast period due to increasing investment in R&D coupled with rising demand for advanced cancer treatment.

High incident rate of cancer, favorable reimbursement for biologics and rising demand for monoclonal antibodies, vaccines and gene therapy will drive France cell line development market over the coming years. Presence of associations such as The French National Cancer Institute (INCa) working towards reducing cancer prevalence will positively impact the industry growth.

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data Sources

1.4.1. Secondary Paid Sources Unpaid Sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Cell line development industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Source trends

2.1.4. Cell line type trends

2.1.5. Application trends

2.1.6. Regional trends

Chapter 3. Cell Line Development Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers Rise in production of vaccines globally Increasing number of cancer incidences especially in developing countries such as India and China Extended applications of biotechnology sector Patent expiration of blockbuster biologics leading to innovations in the field Escalating demand for monoclonal antibodies in U.S. and Europe Technological advancements in cell line development

3.3.2. Industry pitfalls & challenges Ambiguous regulatory landscape Growing concerns related to stem cell research

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By source

3.4.3. By cell line type

3.4.4. By application

3.5. Porter's analysis

3.6. Regulatory landscape

3.6.1. U.S.

3.6.2. Europe

3.6.3. China

3.7. Company landscape, 2017

3.7.1. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Cell Line Development Market, By Product

4.1. Key segment trends

4.2. Reagents and media

4.2.1. Reagents and media market, by region, 2013 - 2024 (USD Million)

Chapter 5. Cell Line Development Market, By Source

Chapter 6. Cell Line Development Market, By Cell Line Type

Chapter 7. Cell Line Development Market, By Application

Chapter 8. Cell Line Development Market, By Region

Chapter 9. Cell Line Development Market Company Profiles

Request a discount on standard prices of this premium report at:

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Cell Line Development Market growth? GE Healthcare, Thermo Fisher Scientific, Lonza Group, Cytovance Biologics, Sartorius, Corning, Selexis, Vista Biologicals, EuBiologics, Paragon Bioservices, Cobra Biologics, Patheon, Samsung Biologic here

News-ID: 1979140 • Views: 229

More Releases from

Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides

All 5 Releases

More Releases for Cell

Single Cell Analysis Market
Single Cell Analysis Market Size Worth $ 4,752.19 Million By 2026 | CAGR: 18.4% The global Single Cell Analysis market size is expected to reach USD 4,752.19 million by 2026 according to a new study by WhipSmart MI Research. The report “Single Cell Analysis Market By Product (Consumables and Instruments), Cell Type (Human, Microbial and Animal), Technique (Flow Cytometers, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry and Other Techniques), Application
Fuel Cell Vehicle Market
The report aims to provide an overview of the global Fuel Cell Vehicle Market with detailed market segmentation by technology, vehicle type, and geography. The global fuel cell vehicle market is expected to witness high growth during the forecast period. The fuel cell vehicle market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market. Get Sample Copy of
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive